With around 16 months before we go to human trials with DX1(hopefully no more delays)the only thing keeping most here is the left field play of DX3...
Was this a stroke of genius by the DR raising the monies to push with DX3?
If this passes the near term tests then im sure we will all be happy, otherwise this wait is going to be one hell of a long one....
Im hoping things are pushed very hard with DX3 and we have a flood of developing partners that want to buy in and develop....
WHAT ELSE IS THERE?
Ann: PAT-DX1 engineering update, page-174
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $43.28K | 6.183M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 237374 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1732079 | 8 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| PAB (ASX) Chart |